Minnie Baylor-Henry - Jun 30, 2021 Form 4 Insider Report for Paratek Pharmaceuticals, Inc. (PRTK)

Role: Director
Signature: William M. Haskel, Attorney-in-Fact for Minnie Baylor-Henry
Stock symbol: PRTK
Transactions as of: Jun 30, 2021
Transactions value $: $0
Form type: 4
Date filed: 7/1/2021, 04:23 PM
Previous filing: Jun 14, 2021
Next filing: Aug 11, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRTK	Common Stock	Award	$0	+19.2K		$0.00	19.2K	Jun 30, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRTK	Stock Option (right to buy)	Award	$0	+12.8K		$0.00	12.8K	Jun 30, 2021	Common Stock	12.8K	$6.82	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units granted to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, pursuant to the Paratek Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, effective January 1, 2021. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest as to 1/3 of the shares subject to the restricted stock units on June 30, 2022, and on the same calendar date of each successive year thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date.
F2	The exercise price is equal to the closing sales price per share of Common Stock as reported on The Nasdaq Global Market on the date of grant.
F3	The stock option shall vest as to 1/36 of the shares on July 31, 2021, and on the last day of each successive month thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer through each vesting date.